Skip to main content

FDA Updates

FDA Grants Priority Review to New Drug Application for the RET Kinase Inhibitor Selpercatinib

Tazverik Receives FDA Approval as First Treatment Specifically for Metastatic or Locally Advanced Epithelioid Sarcoma

Mixed Findings in Annual Cancer Statistics Report

FDA Grants Approval to Avapritinib for Patients with GIST

Recap of FDA Drug Approvals in 2019

December 19, 2019 - FDA News & Updates

Regenerative Medicine Advanced Therapy Designation Granted to ADP-A2M4 for Synovial Sarcoma

FDA Grants Priority Review to Keytruda for Patients with High-Risk, Non–Muscle-Invasive Bladder Cancer

Inrebic Receives FDA Approval for Adults with Myelofibrosis

FDA Approved Erleada for Metastatic Castration-Sensitive Prostate Cancer

14
15
16
17
18
19
20

Page 17 of 33
Results 161 - 170 of 330